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BACKGROUND: Hospital mastectomy rates vary. This study explores the relationship between mastectomy rates and breast cancer
patients’ consultation and decision-making experiences with specialist clinicians.
METHODS: Qualitative semi-structured interviews were conducted with 65 patients from three purposively selected breast units from
a single UK region. Patients provided with a choice of breast cancer surgery (breast conservation therapy (BCT) or mastectomy)
were purposively recruited from high, medium and low case-mix-adjusted mastectomy rate units.
RESULTS: Low mastectomy rate unit patients’ consultation and decision-making experiences were markedly different to those of the
medium and high mastectomy rate breast units. Treatment variation was associated with patients’ perception of the most reassuring
and least disruptive treatment; the content and style of information provision (equipoise or directed); level of patient participation in
decision making; the time and process of decision making and patient autonomy in decision making. The provision of more
comprehensive less directive information and greater autonomy, time and support of independent decision making were associated
with a lower uptake of BCT.
CONCLUSION: Variation in hospital mastectomy rates was associated with differences in the consultation and decision-making
experiences of breast cancer patients. Higher mastectomy rates were associated with the facilitation of more informed autonomous
patient decision making.
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Guidelines state, when breast conservation therapy (BCT) is not
contraindicated on clinical grounds, women with breast cancer
should be offered a choice between BCT and mastectomy (National
Collaborating Centre for Cancer, 2009). Neither treatment is
superior in terms of survival (in cancers up to 5cm diameter) (van
Dongen et al, 2000; Fisher et al, 2002), physical or psychological
morbidity (except body image) (Irwig and Bennetts, 1997;
McCready et al, 2005). However, hospital breast units worldwide
demonstrate widely varying practice (Goel et al, 1997; Morrow
et al, 2001; Ishizaki et al, 2002; Caldon et al, 2005), which is not
explained by case mix (Caldon et al, 2005).
It is commonly supposed that if women were given more choice
over their surgery, the majority would select BCT. Although some
evidence supports this (Degner et al, 1997; Mastaglia and
Kristjanson, 2001), there is also evidence that not all women given
an informed choice will elect to undergo BCT (Keating et al, 2002;
Lantz et al, 2005; Caldon et al, 2008; Collins et al, 2009).
Patients’ health care decisions are subject to many influences. At
the time of diagnosis, women with breast cancer hold pre-existing
values, concerns and knowledge, which can influence their
treatment preferences, including prior information and experience
of breast cancer (Collins et al, 2009), body image values (Schou
et al, 2002; Molenaar et al, 2004), cancer recurrence fears (Nold
et al, 2000; Schou et al, 2002; Molenaar et al, 2004) and attitudes
towards radiotherapy (Schou et al, 2002; Molenaar et al, 2004).
Clinicians may also influence patients’ treatment decisions by
recommending a specific treatment or communicating a particular
preference (Smitt and Heltzel, 1997; Nold et al, 2000; Molenaar
et al, 2004). Limited information is available on how consultations
between breast cancer patients and their clinicians influence
patients’ treatment choices.
This is the fourth paper published from a research study
utilising quantitative and qualitative methodology to examine
variation in hospital breast unit mastectomy rates in a UK region.
Previous papers confirmed case mix does not explain variation in
breast unit mastectomy rates (Caldon et al, 2005), specialist breast
cancer clinicians possess treatments preferences based on cancer,
patient and clinician characteristics (Caldon et al, 2007), and
patients now desire more autonomy in choosing their breast
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scancer treatment (Caldon et al, 2008). This paper presents the
findings of semi-structured interviews conducted among patients
clinicians identified as having been given a choice of surgery (BCT
or mastectomy) from three breast units demonstrated as having
high, medium and low case-mix-adjusted mastectomy rates. It
explores the consultation and treatment decision-making experi-
ences of women newly diagnosed with breast cancer to identify
themes associated with variation in breast unit mastectomy rates.
PATIENTS AND METHODS
Study design
Qualitative methodology was chosen to explore how specialist
clinicians influenced patients’ choice of surgery (BCT or mastect-
omy). Semi-structured interviews were employed to capture rich
data on the topics of pre-determined interest, while providing
sufficient flexibility to capture emergent themes in allied areas of
interest.
The interview schedule was developed by the research team,
including experienced qualitative researchers, two surgeons, one
breast care nurse (BCN) and two consumer representatives.
Prior to conduct, Multicentre Research Ethics Committee and
relevant Local Ethics and Research Governance approvals were
obtained.
Setting and sample
The study was conducted in three purposively selected specialist
breast units from a single UK region: Trent with population
approximately 5 million. The observed:expected mastectomy rates
of the high, medium and low mastectomy rate units were 1.30, 1.03
and 0.48, respectively, based on the case-mix adjustment of
cancers o15mm diameter (n¼1399) diagnosed through the
region’s National Health Service Breast Screening Programme
(1997–2001) (Caldon et al, 2005); that is correcting for patient age,
cancer grade and location within the breast, the high mastectomy
rate unit performed 30% more mastectomies, the medium rate
unit 3% more mastectomies and the low rate unit 52% less
mastectomies than expected for this subgroup of cases treated by
the region. All units followed similar routine practice guidelines
and had similar access to radiotherapy and breast reconstruction.
Patients were recruited via the previously published question-
naire phase of the wider research study from high, medium and
low mastectomy rate breast units (Caldon et al, 2008). Potential
questionnaire participants were purposively identified by their
own breast unit clinicians as being those offered a choice between
BCT and mastectomy, and able to provide informed consent to
participate in research. Patients were approached following their
surgery. The recruitment process and eligibility criteria are fully
described elsewhere (Caldon et al, 2008). To explore the
experiences of the range of patients given treatment choices, a
sampling frame (Marshall, 1996) was used to identify potential
interviewees from questionnaire participants willing to be inter-
viewed, balancing treatment undertaken and breast unit mastect-
omy rate. Reports of similar studies suggest that response
saturation could be achieved by interviewing approximately 20
patients per breast unit. By convention, this is the point where no
new themes or information emerge on data analysis (Marshall,
1996). Seventy-seven per cent (274 out of 357) of patients
completing the questionnaire agreed to be contacted for follow-up
interviews. The first 65 consecutive eligible patients fulfilling the
sampling frame requirements were interviewed over an 8-month
period. Data analysis was performed alongside data collection and
interviews ceased on attainment of response saturation. Twenty
patients were interviewed from the low and medium mastectomy
rate units, and 25 from the high mastectomy rate unit.
The participants were a median 58 years old (range 33–73
years). The mean time between surgery and interview was 6 weeks
(range 1.9–20.6 weeks). Overall, 74% underwent BCT (n¼48) and
26% mastectomy (n¼16). Four of the breast conservation patients
required additional surgery for more extensive disease than
identified pre-operatively: one underwent re-excision of margins
from the high mastectomy rate unit and three had mastectomy
(two from the medium and one from the low mastectomy rate
unit).
Data
The interview schedule was designed to provide a description of
the patient’s surgical treatment decision-making experience.
Information about consultations with multi-disciplinary breast
team members was gathered, focussing on the content and style of
consultations, patients’ comprehension of information provided
and how these influenced treatment decisions. Information was
also sought on patients’ treatment and preconceptions, informa-
tion and experiences of breast cancer.
Interviews varied in length between 26 and 120min (median
51min). All were digitally recorded and transcribed verbatim.
Field notes were also kept.
Data analysis (the framework approach)
Interview transcripts and field notes were analysed using the
framework approach (Pope et al, 2000; Richie et al, 2003). This
provides a rigorous, comprehensive, systematic method to manage
and analyse large volumes of textural data.
The familiarisation phase and generation of the thematic
structure were conducted by three researchers and two consumer
representatives. To minimise bias and improve the reliability of the
analysis, 20% (n¼12 out of 65) of the interviews were
independently coded and charted by two experienced qualitative
researchers (one clinical and one non-clinical) as an ongoing
process. Subsequent detailed discussion of such analyses ensured
consistency and agreement within interpretation and the develop-
ment of themes throughout analysis. Framework matrices were
explored within and between cases, breast units and themes.
*Footnote transcription conventions Any words appearing
between two square [] brackets indicate where notes of clarifica-
tion have been added by the author(s). Ellipsis points indicate
where a quotation has been abridged. Following each quotation,
the participant’s identification number is reported along with their
treatment, age and the type of breast unit treated by. This is
followed by the page number(s) identifying the extract within the
flow of the interview.
RESULTS
There was heterogeneity of patients’ experiences within the units.
However, the decision-making experiences of women from the
medium and high mastectomy rate units were similar, and
differences existed between these and those of patients treated
by the low mastectomy rate breast unit. The themes identified
clustered into two main groups: patient-specific themes and breast
unit-specific themes. Table 1 summarises the themes and sub-
themes associated with variation in patients’ treatment decisions.
Patient-specific themes
Concordant with previous studies outlined in the introduction,
anecdotal information about patients’ preconceptions regarding
breast cancer and its management emerged from the interviews. The
patient-specific themes were generally expressed heterogeneously
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swithin and across the breast units, and were predominantly
independent of breast unit influence. However, two patient-
specific sub-themes were associated with variation in patients’
treatment: perception of the most reassuring treatment option and
perception of the least disruptive treatment option. Table 2
summarises these sub-themes and factors.
Most reassuring treatment option. Although patients were aware
of and accepted the equivalence of survival with BCT and
mastectomy, the extensiveness of surgery often influenced
perception of safety. Many choosing mastectomy said this option
reduced their anxiety about the completeness of cancer excision,
the need for further treatment and some felt it improved long-term
outcome.
*‘[I could] never haveyhad as much peace of mind if I’d just
had the lump removed, ywhat if they’ve missed a little bit
round it.’ [Patient 1, mastectomy, age 42, medium mastectomy
rate unit, p5]
Some felt because they were offered BCT, their cancer was not as
bad or harmful as it might have been. A few believed that this
meant they were more likely to be cured. This was particularly
predominant among patients of the low mastectomy rate unit.
‘Total mastectomyyconjures upyyou are riddled with
cancerywide local excisionycontains your thoughts that it’s
not as bad as your brain’s telling you.’ [Patient 27, BCT, age 61,
high mastectomy rate unit, p9]
While most patients based their decisions on information
provided by the clinicians, some based it on health beliefs within
family or community.
‘Mastectomyymuch bigger operation, but feel that the
problem’s gone, it’s not going to recur in the breast tissue
because it’s not there anymore.’ [Patient 31, mastectomy, age
64, high mastectomy rate unit, p11]
Patients also utilised anecdotal experiences to decide their
treatment.
‘I do know several people who’ve had just the lump removed
and in a year or two they’ve had to go back and have a
mastectomy.’ [Patient 35, mastectomy, age 65, high mastectomy
rate unit, p9]
Least disruptive treatment option. Patients also chose their
surgery based on what seemed the least disruptive treatment
option. For some it meant the option, which would cause least
disruption to their wider life and commitments during treatment,
with a shorter hospital stay (BCT) or overall treatment (mastect-
omy).
‘It was a heck of a lot [of a time commitment]ythat would
absolutely devastate my lifeyas I live it, so unlessyI’d no
choice, I didn’t want [radiotherapy].’ [Patient 16, mastectomy,
age 73, medium mastectomy rate unit, p9]
For others, the least disruptive treatment option was determined
by the potential impact of surgery on body image or sexual
relationship. So breast preservation was extremely important and
mastectomy would be a reminder of the cancer.
‘If you’re disfiguredyit’s a constant reminder that you’ve got,
had or in remission of canceryevery time you look at
yourself.’ [Patient 42, BCT, age 60, high mastectomy rate unit,
p23]
Although body image concerns predominated among those
choosing BCT and fear of recurrence predominated among those
choosing mastectomy, many vacillated, trading between their
concerns regarding safety and recurrence, and the disruption of
normality and body image.
Although these have been classified as patient-specific themes,
the decision-making considerations of patients undergoing BCT
from the low mastectomy rate unit were less likely to include the
possibility of postoperative re-excision or the need for radio-
therapy. In contrast, medium and high mastectomy rate unit
patients voiced such information readily and utilised it when
making treatment decisions.
Breast unit-specific themes
The breast unit-specific sub-themes related to treatment variation
were information content and style; time and decision-making
process and patient autonomy in decision making.
Information content and style. Patients’ treatment choices were
influenced by the content and style of information provided by
their breast units. While individual variation between surgeons of
the same breast unit was noted, more pronounced differences were
evident between surgeons of the different breast units. Table 3
summarises these sub-themes and factors.
Low mastectomy rate unit patient accounts focussed on their
clinicians’ reassurance regarding their cancer and its treatment,
along with treatment recommendations. Patients were more likely
Table 1 Themes and sub-themes associated with variation in patients’
treatment decisions
Patient-specific themes
Most reassuring treatment option
Least disruptive treatment option
Breast unit-specific themes
Information content and style
Time and process of decision making
Autonomy: level of patient participation in decision making
Table 2 Patient-specific sub-themes associated with variation in patients’
treatment decisions
Most reassuring option
Safety and fears
Cancer fully removed
Survival
Local recurrence
Minimise the psycho-physical impact of the cancer diagnosis (implication
of better prognosis with less extensive surgery)
Anecdotal information/experiences
Positive or negative anecdotal experiences
Least disruptive option
Minimise impact on life, relationships and social commitments
Social commitments
Family (especially partners and dependents)
Minimise hospital treatment experience
BCT – shorter in-patent stay
Mastectomy – shorter overall cancer treatment (minimise need for
radiotherapy and re-excision)
Minimise the psycho-physical impact of surgery
Body image disruption minimised with BCT
Potential impact on partners and relationships
Mastectomy as a constant reminder of cancer
Abbreviation: BCT¼breast conservation therapy.
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sto only be offered BCT, even if requesting information about
mastectomy or expressing a preference for it.
‘I went in andy[the consultant] said what they wanted to do,
this operation and take it away [BCT]yAnd I just said to her
‘Well why don’t you just take the whole lot offyand she
saidyshe didn’t think there was any need whatsoever to go to
those extremes.’ [Patient 60, BCT, age 57, low mastectomy rate
unit, p13]
In contrast, patients from the medium and high mastectomy rate
units typically recounted much more detailed descriptions of the
information provided about both BCT and mastectomy, what
undergoing each would involve, the potential consequences and
the amount of time they had for decision making.
‘He went through the various options that I could takeyhaving
the lump removed and going for follow-up treatment radio-
therapy, and which would be a five-week [course]yor the
mastectomy. He also went through the pros and cons of each
oneyand wrote this down.’ [Patient 9, mastectomy, age 50,
medium mastectomy rate unit, p4]
Patients described the different roles clinicians had in providing
information for making decisions. Doctors were viewed as primary
information providers, while BCNs reiterated, reinforced and
explored information needs. Patients of the high mastectomy rate
unit often described extensive discussions with their BCN and a
thorough process of checking understanding. Low mastectomy
rate unit patients felt that BCNs were generally uncomfortable
extending the consultant’s consultation. This was most notable
when patients expressed a treatment preference at variance with
their doctors’ recommendations.
‘I said, ‘Well what happens if I just have the whole breast off,’
and she [BCN] said, ‘Well that’s something you’ll have to
discuss with your surgeon, I can’t tell you that.’ [Patient 60,
BCT, age 57, low mastectomy rate unit, p7]
Within the information style sub-theme, four factors were
associated with patients’ choices, contextualising information,
emphasis and minimisation, accessibility of information and
treatment recommendations.
Contextualising information: Patients being involved in the
choice of their surgery were contextualised differently. The
medium and high mastectomy rate units tended to introduce the
concept and explain the rationale early within the consultation,
leading patients to expect involvement in decision making.
‘He was sayingysome women like the choiceysomeyprefer
one to the anothery they’re equal, there is no better option.
The choice is yours.’ [Patient 42, BCT, age 60, high mastectomy
rate unit, p5]
Most patients from the low mastectomy rate unit did not
describe the provision of such information.
‘He said, ‘I’m sorry, it is malignant, but it is very, very small,
you will need to have an operation. I think it would be
appropriate for you to have a lumpectomy.’ [Patient 63, BCT,
age 59, low mastectomy rate R unit, p7]
When patients received information about BCT and had no
recollection of a preliminary introduction of a choice of treatments
being available, they tended to assume that it was either the only
option available or the recommendation of the clinician or unit.
The other type of contextualisation observed was how individual
treatment options were framed; whether this was in an open,
directive or dismissive manner.
‘[The surgeon] said, ‘Normally people with one that’s as small
as you have this incision [BCT], and at the end she mentioned
mastectomy, but you got the impression she didn’t think you
should go along that line.’ [Patient 64, BCT, age 59, low
mastectomy rate unit, p16]
Emphasis and minimisation: Clinicians often stressed or mini-
mised certain cancer characteristics (small size and the early
nature), which influenced patients’ perceptions of the extent of
their disease and which treatment they should undergo.
‘[The surgeon] said it was only a diddy [very small] one,
that it hadn’t grown very big and, it had started to invade
slightly but they hoped it wasn’t in the lymph nodesythe way
[they]yexplained the cancer made me feel a mastectomy
wasn’t necessary.’ [Patient 52, BCT, age 53, low mastectomy
rate unit, p6]
Accessibility of information: The language and consultation styles
adopted by clinicians influenced the accessibility of information to
patients. Language varied from everyday to bio-medical. Clin-
icians’ consultation styles varied between open, tailored, two-way
dialogues to a more prescriptive style.
‘He [the surgeon] accepted the fact that I had a brain, I’d been
looking at things andytook my background into account
[and]ywe talked about things as a couple of adults.’ [Patient 6,
BCT, age 56, medium mastectomy rate unit, p7]
‘[The consultant] wasn’t really listening to what I was
sayingyRather than it be a discussion between us, I felt it
was a one-sided discussion.’ [Patient 62, BCT, age 44, low
mastectomy rate unit, p10–11]
Treatment recommendations: There was a tendency for low
mastectomy rate breast unit clinicians to volunteer a treatment
plan early within the consultation, containing recommendations
based on what the clinician felt was most appropriate.
‘I think it would be appropriate for you to have a
lumpectomyy So he didn’t actually say, ‘Which would you
prefer?’ yand he of course was the second person who’d said
Table 3 Information content and style sub-themes
Information content
The facts
Options
Treatment details
Potential consequences
Comparison of treatments
Time for decision making
Information style: spectrum from equipoise to forceful direction
Contextualising information
Framing of involvement in decision making
Framing of the options: open/directive/dismissive
Emphasis and minimisation
Cancer size
Implication of ‘early cancer’
Mastectomy as more a more extreme option
Accessibility
Language and terminology: everyday language vs bio-medical
Consultation style: two-way dialogue vs prescriptive; tailored vs universal
Recommendations
Provided or not
Overt vs perceived
Volunteered vs provided on request
Timing of recommendation: early vs delayed
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swhat the course of action would be.’ [Patient 63, BCT, age 59,
low mastectomy rate unit, p7]
In contrast, the medium and high mastectomy rate clinicians
tended to provide patients with more open and comprehensive
information and the opportunity to choose.
‘They were very clear that this was going to be my choice and
that they wouldn’t push one against the other. They just simply
presented all the facts about the two.’ [Patient 33, BCT, age 57,
high mastectomy rate unit, p6]
Some patients, immediately after diagnosis, felt underprepared
for a role in decision making and asked their clinician’s
recommendation. At this point, the medium and high mastectomy
rate clinicians usually spent more time discussing options and
emphasising the time and support available for such a decision,
while low mastectomy rate clinicians tended to recommend a
treatment.
The force of clinicians’ recommendations varied in a spectrum
between encouragement to consider both options with a gentle
steer, to a form of recommendation where patients felt they were
denied their preferred treatment.
‘I was, ‘Get it off, cut it off.’ And she wasyvery kind, very
understanding butyvery gently steering me to the outcome
that she wanted.’ [Patient 48, BCT, age 38, low mastectomy rate
unit, p16]
‘Mr __ said to mey‘I don’t like doing mastectomies’
ySoythere was no discussion really on having my whole
breast offyAnd every time I brought up the subjectyhe
wasn’t really listening to what I was saying.’ [Patient 62, BCT,
age 44, low mastectomy rate unit, p12]
Time and process of decision making. The process of decision
making varied between the breast units. It was generally more
rapid in the low mastectomy rate unit and patients reported
pressure to make an immediate decision. This was reinforced in
the low mastectomy rate unit by all, but one consultant frequently
consenting patients on the day of diagnosis, immediately after
treatment discussion.
‘I found it a very hard decision [I]ycouldn’t decide at allyI’d
got to decide there and then whether I had a mastectomy or a
lumpectomyyso I decided on the lumpectomy and within
minutes all the paperwork was there.’ [Patient 51, BCT, age 51,
low mastectomy rate unit, p7]
Although most recalled being told they could alter their consent
should they change their mind, in practice, this could prove a
challenge.
‘yafter thinking long and hardyI rang up the breast care
nurses the week before my operation was due, and I made an
appointment to go and speak to Mr__ybecause I’d decided by
then I wanted the whole thing off. ySo I went to see him
yand this is quite important to me really – I felt I was talked
out of the mastectomyythere was no sort of discussionyhe
wasn’t really listeningyI feel that Iywent with what he said,
rather than what [I wanted]yI’d gone in there to tell him I
wanted a mastectomy and to rip up the consent form and sign
another one. yI’d done the consent formybut I was told all
the way through thatythat can be ripped up half an hour
before the operation.’ [Patient 62, BCT, age 44, low mastectomy
rate unit, p9–10]
In contrast, the medium and high mastectomy rate unit’s
patients found the process of decision making less rushed. They
were almost universally provided with clear information early in
the consultation about the date of their surgery and were told they
had until then to make a decision. Patients often expressed that
they needed to spend time away from the clinical environment
following their diagnosis, to think and reach a decision.
‘Knowing I’d got this fortnightyAnd being told two or three
times I didn’t have to make a decision there and then, I could
leave it right ‘til the morning of the operationyhelped. SoyI
didn’t panicyI’d got this [time], I was going to come home,
and there’s no place like home for thinking things through
without any pressure.’ [Patient 31, mastectomy, age 64, high
mastectomy rate unit, p8]
Autonomy: level of patient participation in decision making. A
large proportion of patients initially assumed that they would be
given a treatment plan, and expressed surprise when offered choice
of treatment instead. However, after an explanation about why a
choice was offered, most desired participation in the decision.
Breast units had a substantial impact on the autonomy patients
assumed in the selection of their treatment. Discrepancies in power
arose following patients’ new diagnosis of cancer. Disparities in the
knowledge and experience of patients and clinicians were
compounded by the amount of time patients perceived they had
for decision making. Discrepancies were more pronounced among
low mastectomy rate breast unit patients and were reinforced or
moderated by clinicians’ information provision and consultation
skills.
‘[The consultant’s] not intimidating in that wayybut you do
feel as though you’re slightly walking on eggshellsythe trouble
is you’re in a very, very vulnerable positionythere are some
questions you wouldn’t ask because you don’t want to upset
people, because you feel they’re in charge of your life.’ [Patient
49, mastectomy, age 59, low mastectomy rate unit, p17–18]
Doctors seemed to exert the more powerful influence, and BCNs
often adopted empowering techniques.
‘Because there was two doctors in the room and I didn’t have a
[Breast Care] nurse in with meywhen I had a breast care nurse
with me before, we were all involved in the conversation so I
felt I had my support with meyI just felt a little bit, not
intimidated, because he’s not an intimidating man, I just.’
[Patient 62, BCT, age 44, low mastectomy rate unit, p11–12]
Patients of the low mastectomy rate unit tended to experience
simpler and more rapid decision making than patients from the
other units, as their surgery tended to be directed by clinicians. In
contrast, decision making within the medium and high mastect-
omy rate units tended to be more complex, with patients often
describing periods of reflection and deliberation. Although some
found the decision-making experience quite challenging, on
reflection, patients often felt proud of the achievement, owned
the decision and expressed confidence in the treatment chosen.
‘I’ve changed my mind as things have progressedyinitially I
was angryyI thought they should make the choice, they’re the
experts. But now I’m glad that I had the choice because I’ve
made the choice and I’ve got to live with it. And I am quite sure
that I made the right choice.’ [Patient 24, mastectomy, age 60,
high mastectomy rate unit, p27–28]
DISCUSSION
This study provides new information on the clinical consultation
and decision-making experiences of women with breast cancer
who are suitable for BCT, and may explain the reasons why
mastectomy rates vary between different hospital breast units.
While patient-specific themes affected patients’ treatment choices,
the specialist clinicians’ and units’ influence was often the
foremost. In particular, the paper elucidates how patients’
decisions were influenced by clinicians in both overt and subtle
Variable mastectomy rates and consultation differences
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sways. Differences in patients’ information, as well as the
experience of information provision and decision making were
associated with variation in mastectomy rates.
The study reveals how patients’ decisions were affected by the
treatment options they are offered, the content and style of the
information provided by their clinicians (equipoise or directed)
and the level of patient autonomy and time provided for decision
making. While individual variation between surgeons of the same
breast unit was noted, more pronounced differences were evident
between surgeons of the different breast units. Among patients
participating in the study, those from the low mastectomy rate unit
recalled less comprehensive more directive information, less
autonomy and less time for decision making. Conversely, patients
from the high and medium mastectomy rate units described the
provision of more comprehensive less directive information,
together with greater support and time for more autonomous
decision making. The themes associated with differences in breast
unit mastectomy rates are summarised in Table 4. The provision of
treatment choices is appropriate given patients’ preference for
increasing autonomy in decision making (Mastaglia and Kristjanson,
2001; Janz et al, 2004; Lantz et al, 2005; Caldon et al, 2008) and the
potential benefits of involving patients in health care decisions,
including optimising patient well being (Stewart, 1995; Street and
Voigt, 1997; Deadman et al, 2001; Hack et al, 2006) and satisfaction
with the decision-making experience as well as treatment (Street
and Voigt, 1997; Keating et al, 2002; Lam et al, 2003; Lantz et al,
2005; Hack et al, 2006). However, evidence from the current study
(conducted among patients whom clinicians believed they had
offered treatment choices) and others demonstrate patients’
acquiescence to professionals’ preferences and recommendations
(Smitt and Heltzel, 1997; Nold et al, 2000; Molenaar et al, 2004).
Clinicians’ directedness could represent an attempt to counter-
act patient misconceptions. If this were the case, it is reasonable to
anticipate that this group would be better informed. However, in
this study, the converse seemed to be the case; with high and
medium mastectomy rate unit patients often displaying more
comprehensive knowledge of treatment including BCT, than their
low mastectomy rate unit counterparts.
Clinicians are often unsuccessful at gauging their patients’
preferences (Bruera et al, 2002; Janz et al, 2004), and empowering
patients require reciprocal change in clinicians (Butow et al, 2004)
if any, but the most active of decision makers are to truly choose
their treatment. These findings may encourage clinicians to adopt
a more open, tailored and empowering approach in consultations
and foster an active role in treatment selection among those
patients who desire it (Mastaglia and Kristjanson, 2001; Janz et al,
2004; Lantz et al, 2005; Caldon et al, 2008). Methods to empower
patient decision making might include communication skills
training for clinicians, developing the BCN’s role and the adoption
of decision support interventions (O’Connor et al, 2003; Gysels
and Higginson, 2007).
One of the findings of the study is that many patients need to be
given time to recover from the shock of their diagnosis of cancer,
before they are able to engage in decision making. If patients’ more
autonomous decision making is to be supported, the provision of
directive information and treatment recommendations should be
deferred and carefully targeted. This should mean that those who
will benefit from participating in decision making (Street and
Voigt, 1997; Keating et al, 2002; Lam et al, 2003; Janz et al, 2004;
Lantz et al, 2005; Hack et al, 2006) get the opportunity to do so. It
should also permit clinicians to identify and direct the minority
who definitively do not want a role in choosing their treatment, so
that the provision of recommendations is more likely to be based
on the patients’ preference.
Although decision-making experiences varied, most patients
were satisfied with their surgical treatment and decision-making
experience. The exceptions were active decision makers from the
low mastectomy rate breast unit whose treatment preference
differed from the treatment they were recommended, and passive
decision makers from the medium and high mastectomy rate units
who wanted more direction. If the trend for patients desiring
increasing autonomy in decision making (Mastaglia and Kristjanson,
2001; Janz et al, 2004; Lantz et al, 2005; Caldon et al, 2008)
continues, units adopting a more prescriptive approach may find
their patients’ satisfaction diminished.
A potential limitation of the study is that participants were
interviewed following the completion of the decision-making
experience. The authors were limited to approaching patients after
surgery due to the sensitive nature of exploring such experiences
in a vulnerable group of patients and ethical constraints within the
United Kingdom. The interviews were conducted within a similar
timeframe to many other qualitative studies exploring treatment
decision making. Although it is possible that recall bias and post
hoc justification may have influenced the findings, we do not
believe that post hoc justification is likely to be a major influence.
Participants clearly articulated their experiences and concerns,
including where conflict existed between their preferences and
outcomes. The findings are also concordant with the results of
Collins et al’s (2009) questionnaire-based study, which was
conducted in the United States throughout breast cancer patients’
decision-making pathway.
This study was conducted within a UK region with demonstrable
variation in the surgical treatment of breast cancer (Caldon et al,
2005). The authors identified high, medium and low mastectomy
rate breast units with adjustment of raw mastectomy rate data for
the units’ case mix, and recruited representative units to
participate. Compared with other UK breast units, the low
mastectomy rate unit reflects outlying practice, whereas the high
mastectomy rate unit lies within the medium rate spectrum
(BCCOM, 2006). Some UK units have mastectomy rates approach-
ing 80%, and it is possible that such units have similar practices to
that of the low mastectomy rate unit in our study, but with a
preference or lower threshold for directing patients towards
mastectomy.
The results of this and other studies (Keating et al, 2002; Lantz
et al, 2005; Caldon et al, 2008; Collins et al, 2009) appear to defy
the conventional assumption that high BCT rates arise from a
more fully informed group of patients being permitted to choose
their own treatment. The findings instead suggest that improving
patient knowledge and involvement in decision making may result
in a reduction in the uptake of BCT.
Although this study was conducted among patients with breast
cancer, the issue of understanding treatment variation and
involving patients in health care decisions is becoming a national
and international priority. Our findings may help to explain and
Table 4 Summary of themes associated with breast unit treatment
variation
Low mastectomy rate unit
Medium and high mastectomy
rate units
Less comprehensive information More comprehensive information
Active direction of choice Reluctance to direct choice
More directive information Less directive information
More volunteering of clinician
recommendations
Less volunteering of clinician
recommendations
Less active support of autonomous
patient decision making
Active support of autonomous patient
decision making
Time pressure for decision making Lack of time pressure for decision
making
Process factors Process factors
Consent early: at diagnosis or
1 week after diagnosis
Consent later: at pre-assessment
clinic or pre-operatively
Variable mastectomy rates and consultation differences
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where treatment options exist, such as de-functioning ileostomy
and reversal rates in colorectal cancer (Koperna, 2003) and the
management of localised prostate cancer (Zeliadt et al, 2006).
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